purpos
reviewto
discuss
recent
insight
relationship
viral
respiratori
infect
asthma
incept
context
longterm
goal
move
toward
prevent
strategi
childhood
asthma
recent
findingsther
strong
evid
respiratori
syncyti
viru
rsv
human
rhinoviru
rv
wheez
ill
import
risk
factor
asthma
incept
mechan
underli
relationship
intens
area
studi
novel
approach
prevent
viru
infect
andor
lessen
sever
associ
ill
variou
stage
develop
import
potenti
tool
effort
aim
primari
secondari
prevent
asthma
summaryvir
respiratori
infect
earli
life
major
sourc
morbid
critic
develop
asthma
mechan
infect
lead
asthma
incept
suscept
individu
emerg
promis
potenti
intervent
current
avail
test
clinic
trial
goal
prevent
diseas
incept
clearli
horizon
major
childhood
asthma
present
wheez
episod
preschool
year
episod
trigger
viral
respiratori
infect
first
year
life
recent
suggest
infect
pathogen
bacteria
may
also
contribut
wheez
young
children
relationship
detect
pathogen
bacteria
airway
asthma
incept
discuss
beigelman
et
al
ref
journal
manuscript
focu
role
virus
asthma
incept
order
defin
role
virus
asthma
incept
import
discuss
asthma
begin
children
least
one
wheez
ill
school
age
mani
children
outgrow
diseas
thu
import
defin
wheez
phenotyp
earli
life
understand
underli
pathobiolog
diseas
children
tucson
children
respiratori
studi
tcr
unselect
birth
cohort
studi
identifi
wheez
phenotyp
persist
transientearli
lateonset
phenotyp
refin
alspac
piama
studi
includ
two
addit
phenotyp
intermediateonset
prolongedearli
note
phenotyp
associ
virusinduc
wheez
episod
clear
distinct
among
phenotyp
degre
underli
atop
featur
present
children
intermediateonset
lateonset
persist
wheez
children
common
featur
increas
allerg
sensit
atop
featur
importantli
three
phenotyp
also
strongli
associ
childhood
asthma
develop
unfortun
wheez
phenotyp
defin
retrospect
school
age
clinic
util
current
limit
due
challeng
perform
pulmonari
function
invas
studi
young
children
retrospect
natur
wheez
phenotyp
describ
understand
wheez
phenotyp
relat
airway
chang
earli
life
limit
previous
report
lung
function
significantli
lower
infanc
reduc
school
age
children
persist
wheez
recent
bisgaard
et
al
demonstr
highrisk
cohort
infant
whose
mother
asthma
infant
went
develop
asthma
school
age
lower
lung
function
birth
suffer
signific
declin
preschool
year
togeth
studi
identifi
preschool
year
critic
window
intervent
prevent
loss
lung
function
time
regard
airway
inflamm
krawiec
et
al
demonstr
wheez
children
median
age
month
increas
number
inflammatori
cell
bronchoalveolar
lavag
bal
fluid
demonstr
eosinophil
predomin
seen
mani
older
children
asthma
saglani
et
al
perform
bronchoscopi
biopsi
recurr
wheez
children
identifi
reticular
basement
membran
rbm
thicken
eosinophil
inflamm
common
featur
childhood
asthma
present
year
develop
year
age
children
recurr
wheez
howev
airway
smooth
muscl
thick
find
correl
asthma
diagnosi
school
age
follow
studi
publish
recent
clearli
new
technolog
nonion
magnet
reson
imag
need
use
young
children
provid
greater
understand
airway
chang
development
earli
life
respiratori
viral
infect
rang
sever
asymptomat
caus
ill
sever
enough
lead
hospit
improv
molecular
diagnost
led
identif
new
speci
type
respiratori
virus
respiratori
syncyti
viru
rsv
human
rhinoviru
rv
influenza
parainfluenza
bocaviru
adenoviru
coronaviru
human
metapneumoviru
detect
young
children
wheez
ill
rsv
rv
frequent
trigger
wheez
ill
thu
role
asthma
incept
focu
review
rsv
common
caus
sever
lower
respiratori
tract
ill
lead
hospit
infanc
particularli
first
month
life
earli
life
rsv
wheez
episod
associ
develop
recurr
wheez
numer
studi
relationship
strongest
children
sever
rsv
ill
lead
hospit
mechan
emerg
anim
model
human
studi
identifi
pathway
rsv
could
modifi
airway
immun
develop
lead
asthma
incept
highest
level
evid
date
causal
role
rsv
develop
recurr
wheez
recent
report
blanken
et
al
perform
clinic
trial
preterm
infant
compar
palivizumab
monoclon
antibodi
use
rsv
prophylaxi
versu
placebo
prevent
wheez
found
palivizumab
treatment
rsv
season
led
signific
reduct
wheez
day
rate
recurr
wheez
defin
episod
st
year
life
find
provoc
howev
unclear
whether
translat
prevent
childhood
asthma
strength
associ
rsv
ill
infanc
particularli
ill
sever
enough
lead
hospit
subsequ
recurr
wheez
lessen
age
nonsignific
age
year
tcr
may
relat
recent
observ
matern
atop
asthma
risk
factor
rv
rsv
wheez
atopi
clearli
pivot
risk
factor
persist
childhood
asthma
nonetheless
follow
children
enrol
trial
school
age
beyond
prove
inform
rv
second
common
caus
wheez
respiratori
ill
first
month
life
becom
commonli
detect
pathogen
wheez
ill
month
age
rv
wheez
ill
strongli
link
childhood
asthma
incept
fact
wheez
ill
caus
rv
first
three
year
life
associ
increas
risk
childhood
asthma
compar
risk
associ
rsv
wheez
rv
wheez
ill
infanc
link
lower
lung
function
schoolag
whether
repres
caus
effect
rv
wheez
ill
clear
studi
relationship
rv
infect
asthma
incept
particularli
complex
part
due
fact
type
rv
divid
three
speci
b
c
rv
infect
cover
spectrum
asymptomat
sever
diseas
lead
hospit
whether
rv
speci
impact
diseas
sever
enhanc
interest
recent
lee
et
al
perform
longitudin
studi
includ
sampl
infant
period
well
ill
found
rv
c
infect
much
like
lead
moderatetosever
respiratori
ill
rv
b
infect
sever
studi
suggest
rv
c
infect
like
lead
sever
ill
includ
sever
enough
lead
hospit
compar
rv
b
infect
mechan
underli
enhanc
ill
sever
rv
c
current
unclear
import
area
studi
intrigu
geneenviron
interact
relat
rv
infect
earli
life
asthma
incept
recent
identifi
replic
genet
suscept
locu
childhood
asthma
caliskan
et
al
found
genotyp
impact
risk
subsequ
asthma
specif
children
develop
wheez
ill
rv
infect
earli
life
earli
life
allerg
sensit
identifi
import
risk
factor
asthma
incept
sensit
greater
number
allergen
higher
level
antigen
specif
ige
link
enhanc
risk
wheez
asthma
incept
sequenti
relationship
allerg
sensit
lead
viral
notabl
rv
wheez
earli
life
recent
identifi
asthma
establish
rv
infect
children
sensit
expos
aeroallergen
like
trigger
asthma
exacerb
highlight
import
allerg
sensit
rvinduc
asthma
exacerb
children
treatment
omalizumab
antiig
elimin
fall
spring
peak
asthma
exacerb
inner
citi
children
intervent
trial
provid
direct
evid
inhibit
igemedi
pathway
includ
inflamm
lead
reduct
viral
lower
respiratori
ill
sever
base
upon
recent
find
cox
et
al
may
particularli
import
modif
ill
sever
rv
c
infect
mechan
allerg
sensit
exposur
enhanc
viral
ill
sever
risk
asthma
exacerb
incomplet
understood
allerg
inflamm
airway
lead
impair
barrier
function
increas
airway
respons
enhanc
mucou
product
allerg
asthma
associ
defici
innat
immun
respons
rv
also
emerg
evid
allerg
sensit
exposur
directli
impair
antivir
respons
virusinduc
type
iii
interferon
product
plasmacytoid
dendrit
cell
pdc
patient
allerg
asthma
impair
crosslink
high
affin
ige
receptor
impair
pdc
ifn
product
may
also
lead
enhanc
inflammatori
respons
airway
taken
togeth
substanti
evid
causal
role
viral
lower
respiratori
tract
ill
rsv
rv
asthma
incept
infanc
earli
childhood
therefor
prevent
rsv
rv
infect
andor
lessen
sever
result
ill
logic
import
target
research
across
translat
spectrum
move
forward
beg
question
promis
approach
achiev
goal
prevent
asthma
incept
agent
current
avail
prevent
rsv
infect
palivizumab
discuss
recent
clinic
trial
support
hypothesi
prevent
rsv
infanc
decreas
rate
subsequ
recurr
wheez
base
upon
morbid
associ
recurr
wheez
preschool
year
clearli
signific
find
howev
import
move
forward
assess
whether
translat
reduct
childhood
asthma
great
interest
develop
vaccin
rsv
proven
elus
date
mclellan
et
al
use
structurebas
approach
develop
rsv
vaccin
direct
specif
antigen
site
viru
target
potent
rsvneutral
antibodi
recent
report
find
anim
model
suggest
approach
yield
great
promis
ribavirin
antivir
current
avail
rsv
use
limit
side
effect
effect
small
molecul
pharmacolog
approach
clearli
need
rsv
remain
elus
date
unfortun
current
avail
therapeut
prevent
rv
infect
part
due
larg
divers
rv
develop
vaccin
remain
challeng
although
effort
produc
effect
vaccin
ongo
potenti
promis
strategi
asthma
prevent
mani
small
molecul
approach
cure
common
cold
test
year
part
quit
disappoint
one
exampl
pleconaril
capsidbind
agent
led
modestli
decreas
cold
symptom
score
shorten
durat
ill
side
effect
medic
interact
hamper
develop
note
rv
c
speci
may
associ
greatest
burden
lower
respiratori
ill
recent
studi
suggest
structur
rv
c
may
led
previous
test
antivir
ineffect
particular
speci
may
neg
impact
studi
small
molecul
date
futur
studi
aim
develop
therapeut
toward
rvc
clearli
prioriti
varieti
strategi
potenti
lessen
sever
rv
infect
target
hostsuscept
factor
sever
diseas
base
upon
strong
associ
among
allerg
sensit
virusinduc
wheez
asthma
incept
exacerb
logic
propos
intervent
aim
prevent
allerg
sensit
andor
allerg
inflamm
potenti
prevent
asthma
develop
omalizumab
monoclon
antibodi
direct
ige
approv
use
patient
allerg
asthma
year
shown
signific
benefit
prevent
asthma
exacerb
year
age
greatest
benefit
seen
patient
sensit
expos
aeroallergen
therefor
use
omalizumab
block
igemedi
inflamm
preschool
children
highrisk
asthma
develop
promis
approach
asthma
prevent
addit
monoclon
antibodi
aim
inflammatori
pathway
shown
promis
prevent
exacerb
adult
patient
refractori
diseas
howev
agent
yet
approv
unit
state
asthma
treatment
would
like
prematur
studi
effect
prevent
diseas
preschool
children
inhal
current
human
trial
adult
potenti
treatment
augment
host
respons
rv
prevent
asthma
exacerb
effect
approach
would
also
warrant
test
children
move
forward
final
great
interest
role
earli
microbi
exposur
develop
allerg
sensit
viral
wheez
asthma
data
rang
earli
life
farm
exposur
pet
exposur
suggest
particular
microbi
exposur
infanc
decreas
risk
develop
allerg
diseas
includ
asthma
mixtur
lyophil
bacteria
recent
report
reduc
rate
wheez
episod
pilot
studi
preschool
children
anim
studi
suggest
potenti
mechan
product
could
prevent
diseas
sum
hypothesi
earli
life
microbi
exposur
could
costeffect
mean
primari
asthma
prevent
intrigu
howev
studi
microbiom
health
diseas
current
infanc
maxim
chanc
success
intervent
studi
remain
prioriti
move
forward
wheez
viral
respiratori
infect
notabl
rv
rsv
common
initi
present
asthma
earli
life
substanti
data
support
causal
role
virus
asthma
incept
asthma
establish
rv
primari
trigger
asthma
exacerb
excit
time
asthma
research
continu
effort
identifi
mechan
virus
interact
suscept
host
induc
asthma
clearli
need
howev
promis
potenti
intervent
current
avail
test
clinic
trial
goal
prevent
diseas
incept
clearli
horizon
viral
respiratori
infect
common
caus
wheez
ill
infanc
earli
life
rv
rsv
infect
earli
life
critic
risk
factor
develop
childhood
asthma
strategi
aim
prevent
rv
andor
rsv
infect
lessen
sever
associ
ill
promis
approach
prevent
asthma
